ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00874133
Recruitment Status : Terminated (Completed due to low number of eligible patients)
First Posted : April 2, 2009
Last Update Posted : December 6, 2013
Sponsor:
Information provided by (Responsible Party):
dickman ram, Rabin Medical Center

March 25, 2009
April 2, 2009
December 6, 2013
March 2009
December 2013   (Final data collection date for primary outcome measure)
Level of improvement of gastric emptying rate [ Time Frame: 6 months ]
Same as current
Complete list of historical versions of study NCT00874133 on ClinicalTrials.gov Archive Site
Improvement in blood glucose levels [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
 
The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis
The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis

Diabetes affects 5.8% of the adult population in Israel (1). Gastroparesis is a syndrome characterized by delayed gastric emptying in the absence of mechanical obstruction of the stomach.Treatment with acupuncture has been described as effective in improvement of symptoms in patients with gastroparesis in a number of patient series. However, this treatment approach has not been tested by means of a controlled randomized clinical study, and neither has the connection between improvement of symptoms and the anatomical-physiological effect of the treatment, if ever, assessed.This study will test the efficacy of motilium (20 mg thrice daily) as compared to acupuncture treatment on the following subjective and objective parameters of 30 patients with diabetic gastroparesis and impaired glucose control:

  1. To compare the degree of GCSI scores improvement before and after treatment with motilium or acupuncture using a validated questionnaire.
  2. To determine the effect of treatment with motilium or acupuncture on gastric emptying rate.
  3. To determine the effect of treatment with motilium or acupuncture on glycemic control.
  4. To compare the quality of life before and after treatment with motilium or acupuncture using the Short Form-36 (SF-36).

This is a randomized, comparative, pilot study, which will compare two treatments: acupuncture treatment vs. treatment with motilium in 30 diabetic patients with impaired glucose control and gastroparesis.

All patients who meet inclusion criteria will undergo gastric scintigraphy and upper endoscopy to assess the presence of gastroparesis and to rule out gastric outlet obstruction. At baseline, all enrolled patients will fill out the Gastroparesis Cardinal Symptom Index (GCSI), the Quality of life questionnaire (SF-36). Subsequently, patients will be randomized to 20 mg motilium thrice daily and after 1 month wash-out period to acupuncture treatment, each treatment will last 12 weeks.

After treatment, patients will undergo a second gastric scintigraphy and will complete the GCSI and the SF-36.

Fasting blood glucose concentrations and HbA1c levels will be determined at the beginning and at the end of the study and at 6 months later as well.

End Points:

Primary: Level of improvement of gastric emptying rate, and improvement in blood glucose levels at the end of treatment, in comparison with tests before treatment.

Secondary: Level of improvement in scores of severity of gastroparesis related symptoms, with quality of life indicators, in comparison with tests before treatment; also, the number of visits to family doctors/diabetic clinics/emergency rooms, as well as use of the medications resulting from diabetic complications will be investigated.

Interventional
Not Applicable
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Diabetic Gastroparesis
  • Procedure: Acupuncture
    Acupuncture treatment for 12 weeks.
    Other Name: Domperidone
  • Drug: Motilium
    20 mg motilium thrice daily
    Other Name: Domperidone
  • Active Comparator: Motillium
    20 mg motilium thrice daily for 12 weeks.
    Intervention: Drug: Motilium
  • Active Comparator: Acupuncture
    Acupuncture treatment.
    Intervention: Procedure: Acupuncture
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
8
30
December 2013
December 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age: 18-80,
  • Diabetic patients of over 10 years duration with impaired glucose control, after at least 6 months of accepted treatment in a Diabetes Clinic by the study staff before inclusion in the study, who exhibit symptoms which could signify the possibility of diabetic gastroparesis.

Exclusion Criteria:

  • Known hyperprolactinemia, systemic or localized neurological disturbances (myopathy, multiple sclerosis, Parkinson's disease, myelopathy), with the exception of diabetic neuropathy, past stomach or esophagus surgery, pregnancy, inability to sign Informed Consent, fear of acupuncture, limb amputation.
Sexes Eligible for Study: All
18 Years to 80 Years   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00874133
004589
Yes
Not Provided
Not Provided
dickman ram, Rabin Medical Center
Rabin Medical Center
Not Provided
Principal Investigator: Ram Dickman, MD RMC
Rabin Medical Center
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP